SCHEMBL31448554

SCHEMBL31448554

CNc1c(Br)cccc1Cc1cc(F)ccc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.35
HTR2A P28223 3/20 0.35
KCNH2 Q12809 1/20 0.35
ALDH1A1 P00352 3/20 0.35
SLC5A2 P31639 2/20 0.33
SLC6A3 Q01959 2/20 0.33
ABCB11 O95342 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
SLC5A1 P13866 1/20 0.33
P2RX7 Q99572 1/20 0.33
TAAR1 Q96RJ0 2/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33
HTR2C P28335 2/20 0.32
NR3C1 P04150 1/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPK14 Q16539 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31448458 0.84 SLC6A2 (0.38) SLC6A4HTR2AKCNH2ALDH1A1SLC5A2
SCHEMBL31448393 0.81 ALDH1A1 (0.37) SLC6A4HTR2AKCNH2ALDH1A1P2RX7
SCHEMBL20084234 0.73 TAAR1 (0.43) SLC6A4HTR2AKCNH2ALDH1A1TAAR1
SCHEMBL31448540 0.70 HTR2A (0.36) SLC6A4HTR2AKCNH2SLC6A3P2RX7
SCHEMBL31448477 0.70 TAAR1 (0.44) SLC6A4SLC6A3TAAR1SMN1; SMN2SLC6A2
SCHEMBL19789825 0.70 TAAR1 (0.39) SLC6A4HTR2AKCNH2ALDH1A1TAAR1
SCHEMBL25430225 0.69 TAAR1 (0.41) SLC6A4KCNH2TAAR1MEN1KMT2A
SCHEMBL29766550 0.69 TAAR1 (0.41) SLC6A4KCNH2TAAR1MEN1KMT2A
SCHEMBL11426617 0.67 ALDH1A1 (0.50) ALDH1A1TAAR1RAPGEF4MAPTMEN1
SCHEMBL10094690 0.67 BCL2 (0.44) SLC6A4HTR2AKCNH2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND KISSEI PHARMACEUTICAL CO., LTD. (JP) 2025-11-27 US disclosed
EP-4512801-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND Kissei Pharmaceutical Co., Ltd. (JP) 2025-02-26 EP disclosed
CN-119343332-A 3, 4-Dihydro-quinolin-2 (1H) -one compounds 橘生药品工业株式会社 2025-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250361210-A1 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND TSHR, TRHR, GHSR SLC6A4 1932/4885HTR2A 1033/4885KCNH2 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.